Related Experiment Video

Updated: May 30, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

CCN3 suppresses mitogenic signalling and reinstates growth control mechanisms in Chronic Myeloid Leukaemia

Lynn McCallum1, Wanhua Lu, Susan Price

  • 1School of Biomedical and Biological Sciences, Portland Square, University of Plymouth, Drake Circus, Plymouth, PL4 8AA, UK.

Journal of Cell Communication and Signaling
|July 21, 2011
PubMed

Insights

CCN3, a tumor suppressor, is downregulated in Chronic Myeloid Leukemia (CML). Restoring CCN3 expression in CML cells reduces growth, enhances apoptosis, and sensitizes them to imatinib, offering new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • CCN3 acts as a tumor suppressor gene.
  • BCR-ABL tyrosine kinase activity down-regulates CCN3 in Chronic Myeloid Leukemia (CML).
  • Understanding CCN3's role in CML pathogenesis is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the functional role of CCN3 in the K562 CML cell line.
  • To establish a stable CCN3 expression model in K562 cells.
  • To evaluate the therapeutic potential of CCN3 restoration in CML.

Main Methods:

  • Stable transfection of K562 cells with CCN3.
  • Cell growth, colony formation, and apoptosis assays (Annexin V binding).
  • Analysis of cell cycle progression and signaling pathways (ERK, AKT).
  • Assessment of cell adhesion and integrin expression.

Main Results:

  • Stable CCN3 expression reduced K562 cell growth by over 50% and colony formation by 29.7%.
  • CCN3 overexpression decreased ERK and AKT phosphorylation, induced subG0 cell cycle arrest, and increased apoptosis.
  • CCN3-expressing cells showed enhanced adhesion and increased alpha 6 and beta 4 integrin expression.
  • Combined treatment with CCN3 and Imatinib resulted in enhanced CML cell death.

Conclusions:

  • CCN3 restores tumor suppressive functions in CML cells.
  • CCN3 re-sensitizes CML cells to Imatinib-induced apoptosis.
  • CCN3 represents a potential therapeutic target for novel CML treatment strategies.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...